Neurotrope is a biopharmaceutical company principally focused on developing therapeutics for Alzheimer's Disease and other neurodevelopment disorders using a drug candidate called bryostatin-1.
For information relating to our Corporate Governance, including management team and Board of Directors, or our Code of Conduct and Ethics and Governance Policies, Click Here
You can check out copies of our Press Releases Here
If you would like to read our SEC Filings, Annual Reports or Proxy Statements,Click Here.
And for information about our stock price and performance, you can Click Here or follow our stock with your financial adviser (OTCQB: NTRPD).
If you have any questions or want more information, please Contact our Investor Relations team.